Skip to main content

News

By Dave Muoio | 04:00 pm | March 10, 2021
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
By Dave Muoio | 03:25 pm | March 10, 2021
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.
By Laura Lovett | 03:25 pm | March 10, 2021
The new AI-driven tech is also able to sequence a whole genome in 30 minutes. 
By Mallory Hackett | 01:50 pm | March 10, 2021
The deal is expected to close in the second quarter of 2021. It will value the combined company at approximately $1.1 billion.   
By Sara Mageit | 07:03 am | March 10, 2021
The Kepler Night Nurse Edge Box uses vision technology to allow staff to monitor patients and respond to physical distress.
By Paulus Torkki | 02:59 am | March 10, 2021
Value-based care implies radical, even disruptive changes to the current practice, say Paulus Torkki, associate professor of healthcare operations management at University of Helsinki and Marianna Imenokhoeva, founder of LinktoMedicine and HIMSS Future50 Leader. 
By MobiHealthNews | 04:01 pm | March 09, 2021
Also: Valo Health closes $300 million for machine learning drug discovery; Blue Note Therapeutics supports its in-development prescription DTx with $26.25 million.
By Laura Lovett | 03:36 pm | March 09, 2021
The company is launching the Fitbit Ace 3 for $79.99. 
By Dave Muoio | 02:34 pm | March 09, 2021
The digital MSK company is looking to bundle the non-invasive, non-addictive pain reduction device alongside the rest of its employer-focused offerings.
By Laura Lovett | 02:13 pm | March 09, 2021
The study looks at menstruation symptoms and features from over 10,000 participants.